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Giulia Praticò1, Qian Gao1, Augustin Scalbert2, Guy Vergères3, Marjukka Kolehmainen4, Claudine Manach5,
Lorraine Brennan6, Sri Harsha Pedapati6, Lydia A. Afman7, David S. Wishart8, Rosa Vázquez-Fresno8,
Cristina Andres Lacueva9,10, Mar Garcia-Aloy9,10, Hans Verhagen11,12, Edith J. M. Feskens7 and Lars O. Dragsted1*Abstract
Identification of new biomarkers of food and nutrient intake has developed fast over the past two decades and could
potentially provide important new tools for compliance monitoring and dietary intake assessment in nutrition and health
science. In recent years, metabolomics has played an important role in identifying a large number of putative biomarkers
of food intake (BFIs). However, the large body of scientific literature on potential BFIs outside the metabolomics area should
also be taken into account. In particular, we believe that extensive literature reviews should be conducted and that the
quality of all suggested biomarkers should be systematically evaluated. In order to cover the literature on BFIs in the most
appropriate and consistent manner, there is a need for appropriate guidelines on this topic. These guidelines should build
upon guidelines in related areas of science while targeting the special needs of biomarker methodology. This document
provides a guideline for conducting an extensive literature search on BFIs, which will provide the basis to systematically
validate BFIs. This procedure will help to prioritize future work on the identification of new potential biomarkers and on
validating these as well as other biomarker candidates, thereby providing better tools for future studies in nutrition and
health.
Keywords: Biomarkers, Food exposure markers, Metabolomics, Systematic review, Literature search methodologyBackground
The importance of diet for improving health and prevent-
ing chronic disease is widely recognized. Indeed, one of the
main goals of modern nutritional science is to understand
the nature of healthy diets in order to bring “healthy nutri-
tion for all” [1]. The measurement of dietary exposure in
interventional as well as observational studies is of crucial
importance for the discovery of unbiased associations be-
tween food intake and health. By far, the most commonly
applied tools for estimating dietary exposure are based on
self-reporting, such as food frequency questionnaires (FFQ)
for the assessment of regular consumption of usual foods
and food diaries (FD) or 24-h recalls (R24h) for a more* Correspondence: ldra@nexs.ku.dk
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Copenhagen, Denmark
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(http://creativecommons.org/publicdomain/zedetailed assessment of short-term food intake. However,
such measurements often contain systematic and random
errors that are inherent to the method used for data collec-
tion [2, 3]. The use of biomarkers of food intake (BFIs)1,
measured in biological samples, may provide a more object-
ive estimate of actual intake, representing a promising com-
plement to the current self-reporting tools [4, 5]. In this
context, metabolomics has opened new opportunities for
BFI discovery and new putative biomarkers are frequently
identified by metabolic profiling of body fluids following
the intake of various foods, meals, or diets. Putative BFIs is
a term used here for compounds associated with food in-
takes based on a single explorative study or which has been
proposed loosely based on knowledge of food composition
and human metabolism. Such markers need further con-
firmation to support their potential as BFIs before being
proposed as candidate BFIs. The candidate BFIs arele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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process, e.g., by confirmation in more human studies, pref-
erably with a different design and/or populations, or by re-
moving implausible entries based on the data collected
from the literature [6]. However, well-accepted markers of
food intake exist only for a very limited number of foods,
and there is a growing interest and an urgent need to dis-
cover and evaluate new BFIs, as well as to re-evaluate those
suggested in publications outside the metabolomics area.
Therefore, experimental studies to identify new BFIs should
be complemented by extensive review of the literature on
potential pre-existing BFIs. This will not only improve
marker identification in metabolomics but also expand the
list of compounds for validation as potential BFIs.
The topic of BFIs has been characterized by a continu-
ous increase in the number of publications over the last
20 years.
Several research groups have summarized the most sig-
nificant findings regarding BFI discovery via untargeted
metabolomics in a number of recent reviews [4, 7, 8]. How-
ever, a systematic collection and evaluation of the literature
available on putative BFIs for specific foods and/or food
groups has never been carried out. A systematic approach
to the identification of putative and candidate BFIs should
follow a rigorous methodology inspired by existing guid-
ance on health and nutrition [9–11]. However, since expos-
ure biomarker analysis and health assessment are quite
different fields, a guideline on BFI reviews will, to some ex-
tent, include a different set of steps and procedures.Fig. 1 Scheme of the currently suggested BFIRev research methodology. The “
is designed for listing candidate food or food group biomarkers (Table I) while a
available. BFIRev is shown here as a decision tree listing the most important ste
researchers independentlyIn this paper, we propose a strategy to carry out an ex-
tensive literature search to identify putative and candi-
date BFIs, which represents the first part of a guideline
for conducting a systematic BFI review, the BFIRev
methodology (Fig. 1). The validation step will be the ob-
ject of a separate paper and will therefore complete the
systematic BFI reviewing process.
Structure of the guideline for a systematic BFI
review
The initial step of the present work involved identifying
the most important food groups to be reviewed for rele-
vant BFIs. In order to obtain good coverage of the food
intake in different population groups within Europe, a
list of nine food groups was initially identified by the
FoodBAll partners. This was based on country-specific
dietary surveys [12] and groupings commonly used in
food frequency questionnaires, such as EPIC [13]. These
nine food groups and several of their specific subgroups
and food items covered are listed in Table 1.
The search methodology was drafted based on the lit-
erature describing similar search strategies and sent for
commenting by all 11 FoodBAll research groups, partici-
pating in this activity. In this case, Allium vegetables
were selected as an example of a food subgroup. The
first version of the search strategy where consensus was
achieved was later adopted for searches of BFIs for sev-
eral other food groups and further modified to the
current version.Guidelines for Biomarker of Food Intake Reviews (BFIRev)” 4-step procedure
lso retrieving important information for biomarker validation, whenever it is
ps. The questions in the diamonds should be assessed by at least two
Table 1 Principal food groups that need investigation by the BFIRev procedure
Food group and related foods Food group and related foods
Non-alcoholic beverages Nuts and vegetable oils
Coffee Nuts
Tea Walnuts
Low-calorie sweetener-containing beverages Almonds*
Sugar-sweetened beverages Hazel nuts
Alcoholic beverages Pistachio
Alcohol as such Macadamia nuts
Beer Peanuts*
Cider Brazil nuts
Dessert wine Other nuts
Red (and rose) wines Oils
White wine Olive oil
Whisky, cognac, gin, and other distillates Sunflower oil
Food of animal origin Flaxseed oil
Dairy products Rapeseed oil
Dairy products in general Legumes
Dairy fat/butter Peas
Milk Soy and misu products
Fermented non-solid dairy products Lentils
Cheeses Chickpeas
Casein and whey protein Beans
Meat Spices and herbs
Meat in general Anise
White meat Basil
Pink meat Black pepper
Red meat Caraway
Offal meat Chili pepper
Processed meat Cinnamon
Cooked and grilled meat Clove
Fish and other marine food Coriander
Fatty fish Cumin
Lean fish (from the sea or from lakes) Curcumin (Turmeric)
Crustaceans and mollusks Dill
Fish Oil Fennel
Eggs and processed eggs Fenugreek
Fruit and vegetables Ginger
Fruit and vegetables in general Lemongrass
Fruit (in a culinary sense) Marjoram
Berries (strawberry, blackberry, raspberry, blackcurrant, redcurrant,…) Nutmeg
Pomes (apple, pear, quince) Oregano
Grapes Parsley
Citrus (orange, lemon, lime, grapefruit, pummelo, clementine,…) Peppermint
Banana Rosemary
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Table 1 Principal food groups that need investigation by the BFIRev procedure (Continued)
Food group and related foods Food group and related foods
Drupes (peach, apricot, nectarine, plum, cherry) Saffron
Other tropical fruits (pineapple, mango, papaya, kiwi,…) Sage
Other fruits (muskmelon, watermelon, persimmon,…) Spearmint
Vegetables Tarragon
Cruciferous (cabbage, kale, broccoli, cauliflower, brussels sprouts) Thyme
Root vegetables (carrot, turnip, parsnip, celeriac, radish,…) Confectionary
Leafy greens (spinach, lettuce, endive, garden rocket) Cocoa
Fruit vegetables (eggplant, tomato, bell pepper,) Chocolate
Gourds (pumpkin, cucumber, squash, zucchini) Liquorice
Allium vegetables (onion, garlic, shallot, leek, chive, ramsons) Sugar-based sweets (bonbons)
Other vegetables (asparagus, artichoke, celery stalk,…) Wine gums
Tubers Other confectionary
Potato
Cassava
Yam
Sweet potato
Jerusalem artichoke
Cereals and wholegrain
Oat and processed oat products
Barley and processed barley products
Wheat and processed wheat products
Rye and processed rye products
Other grains and grain products
Rice
Sorghum
Mixed cereal products
Other cereals and wholegrains
*Although peanuts are botanically classified as legumes and almonds are botanically drupes, they have both been included in the nuts section due to their
nutritional profile
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extensive literature search on putative and candidate BFIs
follows that proposed by the European Food Safety Author-
ity (EFSA) for conducting systematic reviews for food and
feed safety assessments [10], as well as the “Cochrane hand-
book for systematic review on interventions” [9], with proper
modifications for handling BFIs. The PRISMA statement for
the reporting and discussion of the results [11] was also used
to develop the BFIRev guideline. However, the series of steps
finally proposed here have been adapted for literature search
on BFIs. These steps are reported below and will be dis-
cussed in more detail throughout:
1. Designing the review for a specific food group,
2. Searching for relevant BFI research papers,
3. Selecting and screening papers for quality and relevance,
4. Selection of candidate BFIs and data collection from
the selected records,5. Assessing the quality of the included papers on
candidate BFIs,
6. Evaluating the current overall status of BFIs for the
food or food group in question,
7. Presenting the data and results,
8. Interpretation and conclusion.
Our methodology has been designed to obtain the
most extensive coverage of relevant studies on the
discovery and/or application of BFIs in nutritional
studies, with a structured and reproducible strategy.
Therefore, it will share the framework of systematic
reviews for paper searches, screening, and selections
(steps 1–4). Nevertheless, the steps for BFI evaluation
and study synthesis (steps 5–8) will differ significantly
from guidelines for other types of reviews. Table 2
summarizes the steps for the identification and evalu-
ation of BFIs.
Table 2 Typical features of an extensive literature search
methodology on BFIs
Extensive literature search on BFIs
Steps Characteristics of the step
1. Designing the review for a
specific food group
Objective: Identify and evaluate
existing biomarkers for dietary
assessment for a specific food or
food group.
2. Searching for relevant BFI
research papers
Eligibility criteria for inclusion or
exclusion of studies: Pre-defined and
objectively applied.
Inclusion criteria: Eligible study
designs should include any human
study with a well-documented intake
of the targeted food.
Exclusion criteria: Defined case by
case by objective criteria.
Description of the review method:
Systematically documented.
Literature search: Structured in order
to identify the highest number of
relevant results, documented and
reproducible.
3. Selecting and screening papers
for quality and relevance
Defined procedure, documented
results: Identification of a list of
publications containing information
and/or applications of possible
food biomarkers related to the
consumption of a specific food
or food group.
4. Selection of candidate BFIs and
data collection from the included
records
Procedure: Identification of possible
candidate biomarkers and systematic
extraction of information to evaluate
the usefulness of each compound
as BFIs.
5. Assessing quality of included
papers on candidate BFIs
Methodological quality assessment of
included studies: Evaluation of results
in intervention and observational
studies.
Evaluating risk of bias (false positive
identification, missing entries).
6. Evaluating the current overall
status of BFIs for the food group
in question
Synthesis: Systematic synthesis of the
information to evaluate the
specificity and the presence of other
quality information (robustness,
kinetic properties, dose-response,
etc.) on each candidate BFI.
Preparing for systematic validation
7. Presenting data and results Reporting of study results: Reporting
of the paper containing candidate
biomarkers in structured tables and
in the text; non-selected markers are
listed in a supplementary list.
8. Interpretation and conclusion Overall assessment: The usefulness
of the candidate BFIs and/or suggest
possible candidate biomarkers or
combinations of markers for further
investigation and validation.
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In this step of the review process, the objective, review
question, and eligibility criteria for study inclusion or ex-
clusion are discussed.The objective of conducting an extensive literature
search on BFIs is to list the existing candidate BFIs for a
specific food or food group and to provide available evi-
dence for the subsequent systematic evaluation of the
quality of such compounds as BFIs.
The review question relates to specific intake bio-
markers of foods or food groups. Food groups largely in-
clude foods of animal or plant origin but may also
comprise other sources, as in the case of table salt and
certain supplements. Moreover, they differ in their sub-
division related to culinary, technological, biological, or
nutritional practices. Preparing an extensive literature
search of BFIs for foods within a specific food group
should therefore start by drawing up the links from the
overall food group selected and then dividing the food
group into subgroups, all the way to single foods. Taking
vegetables as an example, one must initially decide on
how to subdivide the group and whether fruits used as
vegetables (e.g. tomato, cucumber, eggplant) should be
included into the vegetable group. In the next step, the
major subgroups such as Allium, cruciferous, apiaceous,
green leafy, etc. vegetables should be listed, and finally,
for the last step, the single foods within these groups
should be considered, e.g., for the Allium subgroup spe-
cies such as onion, garlic, leek, shallot, chives, and ran-
som (Table 1). It is well known that several further
subgroupings (including varieties of each of these) exist,
such as various red onions or the Vidalia variety of
onion, and the detail of the search would depend on the
relevance of discriminating between these in nutritional
science. For current dietary instruments, this kind of
detail is highly variable and it usually does not include
varieties, although these are sometimes included in food
composition databases [14, 15]. Decisions on how to
subdivide and what detail to include has direct conse-
quence for the search profile, as well as for the BFI
evaluation step. Therefore, the strategy for each system-
atic review should aim to identify (i) general BFIs for the
food group, (ii) more specific BFIs for relevant food sub-
groups, and (iii) highly specific markers for selected
foods within each subgroup (when this is possible), as
proposed in the list of food groups reported in Table 1.
To achieve this goal, it is necessary to identify the key
elements that will determine the search questions of the re-
view. This will help in defining the eligibility criteria, the
search strategy during the study selection, and the presen-
tation of the results. In reviews of interventions, these cri-
teria represent a combination of clinical aspects (defined
by the acronym PICO). PICO specifies the types of popula-
tion (Participants), Interventions (and Comparisons), and
Outcomes [16]. These criteria can easily be translated and
adapted in a BFI review. In particular, for the identification
and evaluation of existing biomarkers for dietary assess-
ment, we are dealing with descriptive questions about
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which the population and the outcome of interest need to
be specified [10]. The population could be the population
at large or any subgroup. As the aim of conducting an ex-
tensive literature search on BFIs is to identify and evaluate
existing biomarkers for dietary assessment, no limitations
need to be made on the population characteristics of the
subjects. Even though a biomarker may be valid for a spe-
cific population, at this stage, the search should not filter
for any specific geographical area and should include both
healthy volunteers and patients of all ages. However, when-
ever a defined subgroup is selected for a biomarker study,
it must be determined whether this selection might reason-
ably affect the generalizability of the BFIs.
The expected outcome is the existence of a significant
relationship between the intake of a certain food or food
group and the presence of a specific food-related com-
pound or group of compounds in body fluids or tissues.
Such compounds should represent qualitatively and
quantitatively the consumption of that food and be
robust markers in real-life situations in that other foods
or food groups are not likely to yield the same BFI.
One typical feature of an extensive literature search is
the a priori specification of eligibility criteria for includ-
ing or excluding studies in the review. Such criteria are
guided by the key points previously introduced.
Eligible study designs should include any human study
with a well-documented food/dietary intake. This may in-
clude the following categories: (i) intervention studies
(randomized controlled trials over a period of time or sin-
gle meal studies) in which the participants consume
known amounts of specific foods and in which biological
fluids or tissue samples are collected at one or more time
points before and after the trial period and (ii) population-
based studies (cross-sectional studies, case-control studies,
cohort studies) in which the participants are classified and
compared as consumers and non-consumers, high- and
low-consumers, or with defined strata with respect to the
food or food group. Such studies are typically post hoc
with biomarker discovery being their main objective.
These studies may include existing BFIs or a subjective
dietary instrument (e.g., an FFQ or a food diary) to moni-
tor dietary intake. Two main approaches to discover BFIs
should be taken into account: the targeted hypothesis-
driven approach, based on previous knowledge of food
composition [17, 18], and the data-driven approach, pro-
vided typically by untargeted metabolomics studies [4]. In
the first case, the selection of the investigated marker(s)
would be made a priori, based on previous knowledge of a
food-specific constituent. In the second case, the markers
are not known a priori and an untargeted metabolomics
approach is adopted, thereby allowing for the discovery of
novel BFIs, as well as confirmation of previously proposed
markers.In cases where no biomarker studies on a food or
food component can be found, there may be studies
on food compounds that may be specific for that food
or food component. Human studies in which specific
compounds originating from such foods are provided
to volunteers can be used as supportive data on as-
pects related to absorption, distribution, metabolism,
and excretion of that compound. However, these data
cannot be taken as evidence that the compound may
be a BFI for the food in question. Moreover, papers
on nutritional status biomarkers, e.g., related to vita-
mins or minerals, or effect markers [19], should not
be included during the search process for BFIs, as
such markers lack specificity for single foods or food
groups. Animal studies could be considered especially
when human studies are missing and/or when they
provide supportive information on biomarkers identi-
fied in humans. Consequently, BFIs observed only in
animal studies are not eligible as candidate bio-
markers but should be seen as putative biomarkers to
investigate further in human studies. Exclusion cri-
teria are usually made on an ad hoc basis because the
major source of noise in a literature search may come
from unpredictable sources such as the author name
(e.g., John Trial) or specific wording not directly re-
lated to the particular BFI (e.g., allergens in particular
food groups). Regardless, inclusion and exclusion cri-
teria must be listed in the method section.
Searching for relevant BFI research papers
This section outlines the search strategy, selects the
sources of information for the review, and identifies the
keywords for the literature search. In a BFI review, as for
reviews in health and nutrition, authors should list the in-
formation sources used, such as the databases searched,
the keywords used for the search, and the time period in
which the search was conducted. The listed information
must also include details on the targeted food group, sub-
groups, and foods, as well as inclusion and exclusion
criteria for the specific literature search.
Outline of search strategy
Biomarker of food intake reviews should start out defin-
ing as its topic BFIs for a specific food group, subgroup,
or single food. The search for the identification of candi-
date BFIs should be articulated in four steps (Fig. 1). A
preliminary screening (step 1) of the food group compo-
nents should first be conducted in food composition da-
tabases (see the “Information sources” subsection) in
order to determine which specific compounds may be
associated with the intake of the targeted foods or food
group. Such a pre-screening step provides a preliminary
overview of the compounds known to be present in the
targeted food/food group and may help in the following
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not limit the investigation to the food compounds iden-
tified in the search or to their known metabolites, since
some relevant food compounds and metabolites may not
yet have been included in the databases. Following this
initial screening, the primary search (step 2) should
make use of the resources mentioned in the following
section to obtain a list of putative BFIs. This list should
be sorted, based on the authors’ knowledge of (a) candi-
date biomarkers and (b) other compounds, i.e., those
known by the authors to be present in many different
foods. The division into these two groups of compounds
relies heavily on the experience of the researcher and
must therefore be cross-validated by an independent ex-
pert to avoid further work on implausible markers, such
as widespread or even ubiquitous compounds, including
most nutrients. However, this is not always straightfor-
ward; in the case of Allium vegetables, for example,
onion is a good source of quercetin and its metabolites
are abundant in urine after intake, but quercetin is also
well known to be found in many other food items (see
also step 3 below). This raises a flag that quercetin me-
tabolites may not be sufficiently specific to be included.
In cases of doubt, the marker should be placed initially
into the candidate biomarker group. Once the candidate
biomarkers have been identified, a second literature
search (step 3) should be performed to confirm whether
each listed metabolite can be classified as a unique or
characteristic marker for the particular food/food group
or can also be related to the intake of other foods. This
secondary search is also used to obtain additional infor-
mation (e.g., dose response, ADME (absorption, distribu-
tion, metabolism, and excretion) information, and
analytical methodology) to evaluate the usefulness of
each compound as BFIs (biomarker validation step). In
the Allium example, quercetin-3,4′-O-diglucoside was
found by this additional search to be quite specific for
onion [20], but its metabolism leads to the presence in
urine and plasma of common quercetin metabolites,
found after the intake of all plant foods containing quer-
cetin derivatives [21]. Therefore, quercetin may be omit-
ted from the list and retained only if it can be argued
that it would form a necessary part of a multi-marker
approach, where several biomarkers together provide
sufficient specificity for onion. A compound can also be
considered unspecific if its endogenous presence in the
body is high, making it difficult to discriminate whether
the compound is observed as a response to food intake
or not. Compound databases, as reported in the
“Information sources” subsection, should be used for a
first evaluation of potential marker specificity, when the
compound of interest is a food compound or one of its
expected metabolites. Additionally, the Human Metabo-
lome Database (HMDB) [22] can be used to retrieveinformation about endogenous metabolites, such as their
presence in body fluids and the possible metabolic path-
ways that lead to the formation of such compounds. As
a result of this investigation, a compound should be con-
sidered a candidate BFI if it meets one or more of the
following criteria: (i) the marker has high specificity for
the targeted food or food group, such as arsenobetaine
for fish [23] or of alkylresorcinols for wholegrains [24];
long-chain fatty acids might be another example for fish
but they are also present in food supplements so they
would qualify better for a fish intake biomarker pattern;
(ii) the compound is highly characteristic of the food in-
vestigated, e.g., markers that are very high in the tar-
geted food compared to others, such as chlorogenic acid
for coffee [20]; and (iii) the marker is not fully specific
but could be used in a multi-marker approach (e.g., tar-
taric acid is present in grapes but combined with ethyl-
glucuronide may provide a good estimation of wine
intake [25]). Clearly, what will constitute a specific bio-
marker will depend on the population in which the BFI
will be applied and later validation steps will include this
aspect. However, if none of the three aforementioned
criteria are met, the compound should be moved to the
list of not plausible markers. The list of candidate bio-
markers should be reported in a table (step 4), summar-
izing the main information relative to the selected
studies (see the “Presenting data and results” section).
Information sources
The main source of information for the primary search
should originate from original research articles searched
electronically in relevant databases. In order to get the
most comprehensive overview of the scientific papers
available, an optimal search strategy should preferably in-
clude three databases, including PubMed [26], ISI Web of
Science [27], and Scopus [28], as we have observed that
the redundancy of the information on BFIs between these
databases is quite low. If not all the three databases are
available to all research groups, the search could be re-
duced to two databases if necessary, or another relevant
database may be selected. Additional databases, which
could be consulted, include Scifinder [29] and Google
Scholar [30]. A second source of documents may come
from the examination of the reference lists in the relevant
articles retrieved. Such an approach may be particularly
useful to retrieve older research papers that may not be
available through online sources. Relevant reviews and
books should be also consulted to manually search add-
itional original literature. For the preliminary screening
and the secondary search, the use of compound databases,
such as HMDB [22], Exposome-Explorer [31], Phenol-
Explorer [20], PhytoHub [32], the Dictionary of Food
Compounds [33], and FooDB [34], should be included in
the search strategy. Such databases contain information
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or in specific foods. Therefore, they could be used to as-
sess the specificity of a certain candidate BFI (see step 3 in
the previous section) or to propose new putative markers
based on the knowledge of the food compounds. Peer-
reviewed literature should exclusively be used, and litera-
ture useful to interpret, support, and draw conclusions
about biomarker validation should be included when
available. For commonly used biomarkers such as EPA
and DHA for fish or fish oil supplement intakes, the num-
ber of studies may be extremely high and thus highly
redundant. Therefore, their inclusion may be limited to
recent reviews and meta-analyses but should not exclude
methodological studies (e.g., studies on kinetics, analytical
methodology, variability, or other aspects of BFI quality).
The full list of relevant papers may then be added as a
supplement to document the search.Search keywords
The list of search terms for the primary search should
be appropriate in order to capture the relevant literature
but selective enough to avoid capturing irrelevant ones.
The main search strategy should make use of general
keywords to limit the search to BFIs, as well as specific
terms for the food or food group under investigation.
The search should be reproducible in different databases
and make use of the Boolean operators “AND,” “OR,”
and/or “NOT”; however, the names of search fields to
use and filters will vary between databases. In the
method section of the BFI review paper, a full electronic
search strategy should therefore be reported in the for-
mat of at least one of the major databases, including any
limits used, so that the search may be reproduced [35].
The selected criteria should be as follows:
1. The first research criterion has to filter the literature
for the specific food/food group including all the
foods from the food group (e.g., allium OR onion
OR garlic OR leek OR chives OR shallots OR
ransom). If relevant, the scientific Latin names could
also be added as keyword (e.g., Allium cepa OR
Allium sativum, etc.).
2. The next criterion should address the function as a
potential biomarker and its metabolism (e.g., biomarker*
OR marker* OR metabolite* OR biokinetics OR
biotransformation OR pharmacokinetics), where “*”
designates a wild character for the search engine used.
Further terms could be added, according to the specific
information that the scientist would like to obtain (e.g.,
metabolism OR kinetics), but such terms may greatly
increase the number of irrelevant results.
3. Further specification of the intake mode will help to
filter dietary studies from other clinical studies (intakeOR meal OR diet OR ingestion OR consumption OR
eating OR drink*). Terms such as (drink* OR food OR
beverage) may be added when appropriate, but they
may add considerable noise to the search results.
4. An additional search string will limit the search to
human studies: (human* OR men OR women OR
patient* OR volunteer* OR participant*), AND (trial OR
experiment OR study) as a minimum. The string could
be expanded with (individuals OR subjects) for the first
string and (intervention OR cohort OR meal) for the
latter. The decision depends on the signal-to-noise ratio
introduced based on a pilot search (e.g., performed by
limiting the search to the most recent 2 years).
5. A criterion on samples or specific body fluids will
also help to focus the search (e.g., urine OR plasma
OR blood OR serum OR excretion OR hair OR
toenail OR faeces OR faecal water).
6. Animal studies could be considered as they
provide complementary information to human
studies. Information from animal studies may be
the only available option if information from
human studies is missing or lack important
information on potential biomarkers found in the
preliminary search on food constituents. When
taking only human studies into consideration, a
NOT operator could be used with a string such
as (animal OR rat OR mouse OR mice OR pig OR
…). It is important to remember that the NOT
operator may also remove several important
results, for instance where human and animal
studies are published together. Manual removal is
therefore recommended. Whenever a NOT
operator is used, it is advisable that the removed
papers are carefully checked (e.g., searched
separately for information on human studies).
7. Further criteria may be added based on the specific
food or food group. For instance, in the search for
seafood intake biomarkers, “food allergy” could be
an important source of noise and might be avoided
using the NOT operator (“food allergy” OR “food
allergies”).
8. If the food is consumed after processing such as
cooking procedures that may affect the structure of
the molecules or produce new compounds (e.g.,
Maillard reaction products), the processing could be
taken into account in the search, e.g., AND (heated
OR cured OR smoked OR…).
The criteria outlined above should be combined using
AND, except when the NOT operator is specified.
The second literature search, aimed at confirming
marker specificity, as well as obtaining further useful
information for marker validation, should use the (“com-
pound name” OR “compound class”) as the main
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OR metabolite* OR biokinetics OR biotransformation
OR pharmacokinetic* OR ADME OR bioavailability).
Further filters, such as (urine OR plasma OR serum OR
blood OR excretion OR faeces OR faecal water) AND
(intake OR meal OR diet OR ingestion OR consumption
OR eating OR drink* OR administration) AND (human*
OR men OR women OR patient* OR volunteer* OR par-
ticipant* OR subject*), could be added in order to fur-
ther filter the result in case the search produces too
many irrelevant matches.
Selecting and screening papers for quality and relevance
The search process outlined above may provide a
massive number of records that could be largely irrele-
vant for the purposes of identifying and documenting
relevant BFIs. Therefore, the screening procedure
guided by the eligibility criteria should be both effi-
cient and comprehensive. Once the list of criteria to
define eligible papers has been defined, at least two
parallel reviewers should be identified as advised in the
“Cochrane Handbook for Systematic Reviews of Inter-
ventions” [36]. The reviewers must independently carry
out the assessment of the study eligibility and the ex-
traction of data from study reports. This criterion will
help in achieving a consensus between the scientists
involved in the review which will also reduce the risk
of bias in the evaluation of cause and effect. For pri-
mary screening and selection of potential candidate
BFIs, an evaluation by two different researchers is ad-
visable but not strictly necessary because there is usu-
ally less ambiguity in that part of the evaluation.
Instead, two or more expert researchers should evalu-
ate the list of candidate biomarkers following the
primary search to make sure that it contains markers
to be expected based on prior knowledge. Ambiguity
at this step can be resolved by additional primary
searches to target any potentially missing candidate
markers and by screening any available exploratory
untargeted metabolomics studies of markers for the
food or food group in question.
In the final extraction of information from the se-
lected papers, it is important to include information
useful for further validation of the markers. First of
all, the compound information should point to a
unique compound identified by an authentic standard.
In metabolomics, BFIs are often found and even con-
firmed in additional studies although the biomarker
identity cannot be identified by a standard, because
standards are not commercially available or possible
to synthesize. If included, such markers should be
flagged and information about the uncertainty of their
true identity should be clearly mentioned. It should
also be argued why such a BFI is included. To statethis in terms of the Metabolomics Standards Initiative
classification, only level 1 markers (identified by an
authentic standard) should usually be included, except
in special, well-argued cases.
A typical process for selecting and screening papers for
inclusion in a review should include the six steps similar
to those proposed for other kinds of review [36, 37]:
1. Merge all the search results from different databases
using reference management software and remove
duplicate records of the same report.
2. Examine titles and then abstracts for relevance to
the study question to remove obviously irrelevant
records (authors should generally be over-inclusive
at this stage).
3. Retrieve full text of the potentially relevant records.
4. Link multiple records of the same study.
5. Examine full text of the records for compliance with
eligibility criteria.
6. Make final decisions on inclusion of the paper or
report and proceed to data collection.
The selection process should be described, and re-
sults should be reported in a manner that provides
the number of studies screened, their assessed eligibil-
ity, and those that were included in the review. The
reasons for exclusions at each step should also be
documented [35]. In particular, review authors should
include a study flow diagram as recommended by the
PRISMA statement [11, 35] to illustrate the results of
the search, the screening process, and the selection of
studies for inclusion in the review. The flow diagram
should present the number of:
(a)Unique records identified by the searches.
(b)Records excluded after preliminary screening (e.g., of
titles and abstracts).
(c)Records retrieved in full text.
(d)Records excluded after assessment of the full text,
with brief reasons for exclusion.
(e)Papers and reports meeting eligibility criteria for the
review.
(f ) Studies contributing to the list of candidate BFIs.
The secondary search may also make use of a simi-
lar set of steps, but since it depends on single cases,
it is not possible to define a general systematic ap-
proach, and the previous framework should be only
used as an indicative procedure.
Selection of candidate BFIs and data collection from the
included records
The step following the selection of relevant records
consists of identifying candidate BFIs for the food or
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information for the assessment of the usefulness of
the selected compounds as candidate BFIs. Besides
the analysis of the full text of papers obtained from
the primary search as described above, further infor-
mation, such as marker specificity and pharmacoki-
netic properties, could be collected from the records
obtained from the secondary search, as stated in the
outline of the strategy. Papers should be grouped by
the class of compounds in order to facilitate the sub-
sequent evaluation of the information. Such an evalu-
ation targets the evidence that the compound(s) can
show an increased concentration or excretion after in-
take of the targeted food or food group. Ideally, the
biomarker signal or its concentration in body fluids
or tissues should be very low when the food is not
ingested for a sufficient period of time, and it should
increase only in response to the food intake and re-
turn to baseline at an appropriate time point after the
intake ends. Possible information to collect includes
whether there is a significant correlation between the
candidate biomarker level and the intake of a specific
food. In order to confirm the plausibility of the
marker as a BFI, it is also important to provide infor-
mation about its specificity by reporting the relation
between the marker and the food composition, in-
cluding the likely metabolic fate of the parent food
compound in the human body. Such data should be
supported with information about the study, the
population, and the analytical method used to detect
and quantify the compound(s), the kinetics of the
marker(s), and the existence of a dose-response rela-
tionship. Details about the information necessary to
evaluate the usefulness of each candidate BFI are re-
ported in the section “Evaluating the current overall
status of BFIs for the food or food group in ques-
tion.” In some cases, the candidate marker may
already be present at baseline and/or in the control
group, as it could be endogenously produced from
low-level secondary sources of exposure. For such
candidate BFIs, this lack of specificity may be a ser-
ious challenge for their validation. Therefore, informa-
tion on background exposure and the methodologies
used to monitor or adjust for them would be crucial.
Candidate BFIs composed of two or more less-
specific metabolites should be marked as belonging to
this category. Likewise, the reason for keeping them
should be stated. As an example, caffeine may be kept
as a candidate compound for coffee intake biomarker
even though it is present also in tea and in multiple
soft drinks, confectionaries, and other convenience
products.
All this information is used to shortlist candidate BFIs
and will be used more extensively in combination withother biological and chemical information to support
marker validation.
Assessing quality of included papers on the candidate
BFIs
In a BFI review, each study should undergo a standard-
ized assessment to evaluate to which degree it is suscep-
tible to bias. In healthcare research, common types of
bias can occur in many different study designs. They are
often classified as selection, performance, detection, at-
trition, and reporting biases [10]. Because we are inter-
ested in assessing whether a compound found in the
body fluids may be used as a BFI (i.e., to estimate com-
pliance, recent or average food intake), the evaluation of
the full-text papers in a BFI review will be different from
that carried out for reviews on health-related studies. As
a result, the risk of bias will differ, especially as it relates
to decisions based on the knowledge of the reviewer(s)
in areas like food chemistry, human study designs, bio-
marker theory, and biomarker analytics.
The most common bias may be the over-inclusion of
candidate biomarkers. While over-inclusion of candidate
biomarkers is advisable in the first part of the review
process, unwanted bias may also be seen. For instance,
over-inclusion bias could arise from a non-cautious in-
terpretation of correlation analyses in observational
studies. Over the last few decades, a significant number
of studies have used correlations between metabolites
quantified in body fluids and frequency of food intake
assessed by FFQ or other self-assessment tools [38, 39].
Even though correction for random and fixed factors is
applied, such results may lead to an overestimation of
the reliability of the compound as an intake marker. This
is because correlation may originate from other co-
occurring phenomena and cannot be used to infer caus-
ality between the consumption of a food and a change in
the measured biomarker. Examples include studies
showing unspecific increases or decreases in various
lyso-phospholipids [40, 41]. Non-specific BFIs may also
be detected in intervention studies, where the back-
ground diet is highly controlled, thereby decreasing the
robustness of the selected putative marker compounds
identified. For instance, hippuric acid has been found as
a marker that is changing with a large number of differ-
ent plant-based foods. Therefore, in a study with a single
fruit or vegetable, this marker may seem very important
but still be largely irrelevant [42–44]. Another cause of
misinterpretation of BFIs could be the unclear boundary
between BFIs, effect markers, and biomarkers of nutrient
intake. As detailed previously [19], the classification of
nutrition and health biomarkers depends on the
intended use of the biomarker measurement in the
study. Therefore, the reviewer should pay particular at-
tention to identify the purpose for which that compound
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improvements in vitamin A status may have been ob-
served in a deficient population after long-term in-
creased intake of carrots, but this does not mean that
retinol (vitamin A) is a good biomarker of carrot intake
since many other dietary factors would influence
changes in the level of such a compound [45, 46].
Confounders may also originate from the study design. In
some intervention studies, the food is administered concur-
rently with other foods within a meal, with or without a
control group. In these cases, the source of the marker may
not be clearly distinguished if dietary intake is a mix of sev-
eral foods, and the study cannot be used as such. However,
it may be used to support hypotheses based on more direct
evidence from other studies. Other confounders may arise
from environmental sources; one example is the polycyclic
aromatic hydrocarbons, which could originate from the
cooking process rather than from the food itself [47]. In this
case, detailed information about exposure and background
levels should be presented for a proper evaluation of the
suitability of these compounds as BFIs.
Detection bias may also occur in case of limitation in the
analytical method or in sample preparation. For example,
quercetin-4′-O-glucoside was once reported in plasma
after onion consumption [48], suggesting that this com-
pound could be a potential candidate biomarker for onion
intake. However, it was shown that, even though this com-
pound supported absorption of quercetin faster than other
quercetin glycosides [49], its presence in plasma was an
artifact [21, 50].
To investigate the characteristics of a compound or me-
tabolite as a BFI, the included studies should present a
comparison of consumers and non-consumers of the in-
vestigated food. Randomized controlled trials (RCTs) with
a crossover design represent the most sensitive kinds of
studies for the discovery of BFIs. In this design, the com-
parison between interventions can be made on a within-
participants basis. This is because participants act as their
own control, providing a better evaluation of the effect of
the treatment (that in this case would be the meal or the
diet). Most RCTs are not conducted with a primary aim to
observe BFIs, and the control group may be selected with a
view of other aims. Selecting a proper control diet is not
trivial. For a BFI study, the ideal control diet is highly var-
ied and fully balanced in nutrients while avoiding the spe-
cific food or food group in question. In practice, this is
often quite difficult to do, and in single meal studies, it is
often necessary to design a specific control food nutrition-
ally resembling the food under study. The biomarker study
may consequently be contrasting between two foods or
food groups, and this must be taken into account in the
data analysis. Other studies that could be evaluated are
RCTs with a parallel design or quasi-experimental studies
with a before-and-after design. The latter design is lessrobust and cannot be used to assess whether the com-
pound could be a good marker of food intake, but it
may be useful for getting additional information on the
candidate biomarker, such as its kinetics. Moreover,
intervention studies in which different doses of the
same food are given to volunteers represent the golden
standard to evaluate the existence of a dose-response
relationship between the food intake and the presence
of the marker in body fluids and tissues. This avoids
the uncertainties of questionnaires. On the other hand,
these kinds of studies present a highly controlled en-
vironment; therefore, the markers observed may not be
robust and often need to be validated in further stud-
ies, where the background diet is not controlled [51].
Cross-sectional studies provide the optimal conditions
to assess the robustness of candidate biomarkers be-
cause of the highly variable dietary background and
variable intake levels. Case-control studies and pro-
spective studies could be also used to indicate the ro-
bustness of the candidate BFIs in free-living subjects.
However, if sample collection and food intake assess-
ments are not coincident, the association between in-
take and measurements may be weak, especially for
biomarkers of acute intake. In the case of markers
averaging long-term intakes (e.g., carotenoids) or for
foods that are very regularly consumed, biomarker
concentrations can be compared to habitual food in-
take as assessed with a FFQ. These kinds of studies can
result in useful biomarker validation. It has recently
been shown that for many markers, three spot urine
samples separated by several months may be sufficient
to represent the FFQ for the most commonly con-
sumed foods [52]. Other samples may represent other
time frames [53].
Candidate biomarkers may also be initially identified
in observational studies and subsequently validated in
experimental study designs. However, since most obser-
vational study designs are prone to misclassification as
well as to confounding factors, confirmation in an
experimental study is absolutely necessary in the initial
validation of such candidate biomarkers.
Evaluating the current overall status of BFIs for the food
or food group in question
The step following the assessment of candidate BFIs for
the food or food group in question consists of a system-
atic collection of the information from the records ob-
tained from the primary and secondary searches to
evaluate the usefulness of such compounds as BFIs. Such
a collection of information should prepare the reviewers
for the systematic validation of BFIs proposed by our
team in a separate paper and should therefore follow the
same biological and chemical evaluation criteria. Bio-
logical information that should be reported includes:
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a certain food),
 Dose-response relationship between quantity of food
ingested and biomarker response,
 ADME and individual variability,
 Cumulative aspects (e.g., accumulation in tissues),
 Robustness, that is the ability of the biomarker to
indicate the intake of a specific food regardless of
complex meals or diets, food matrix, and individual
and environmental factors, and
 Reliability, which indicates whether a candidate
marker has been validated against other already
validated methods, such as other already validated
BFIs or dietary assessments.
Analytical aspects should include:
 Information on the chemical stability of the
compound,
 Details on the method validation, and
 Analytical reproducibility across laboratories.Presenting data and results
The study selection process typically leads to a list of
publications containing information and/or applications
of putative biomarkers related to the consumption of a
specific food or food group. As described in the search
strategy, a second literature search should be performed
to confirm the specificity of each marker, thereby pro-
viding the list of candidate biomarkers. The records con-
taining information on candidate BFIs should be
reported in a table, as described below (Table I in Fig. 1),
while non-specific markers should be only discussed in
the text and the reason of their exclusion should be ex-
plained. Reports including only non-specific markers
may be reported in a supplementary table in order to
provide all the information collected during the system-
atic search (Table SI in Fig. 1). The BFI table should
contain the following information:
 Food items that associate with the candidate marker;
 Study design;
 Number of subjects included in the study;
 Analytical method(s) applied to identify or quantify
the marker;
 Biospecimen(s) analyzed in the study;
 Chemical name or trivial name and/or identifier(s)
of the candidate biomarker compound(s); identifiers
may be InChI key(s) for the candidate biomarker
compound(s) or another unique identifier (e.g.,
Pubchem ID, Chemspider ID, …);
 Primary reference in which the compound has been
identified or tested.For the supplementary table reporting the records with
non-specific markers, a column reporting the exclusion
rationale should also be added. Anyway, for such table
information such as the number of subjects, the analyt-
ical method may not be required.Interpretation and conclusion of the review
This section should include a description of the quantity
and quality of the evidence supporting the review ques-
tion, the interpretation of the results, any potential limi-
tations of the review process, and agreements or
disagreements with other research [10]. In the process of
carrying out a BFI review, the reviewers should now
have a list of compounds which are either specific or
non-specific for the food or food group in question, as
well as the necessary information to support their valid-
ation as BFIs. Both specific and non-specific markers
should be discussed in the text, underlining the point(s)
of weakness of each non-specific marker. These reasons
may include variations in metabolism or the presence
after intake of other food groups. Additionally, the
strength of the most promising candidate biomarkers
(e.g., specificity for a certain food or food group, exist-
ence of dose-response relationship, robustness in real life
situation, etc.) should also be discussed in the text. Once
the candidate biomarkers have been proposed and evalu-
ated for specificity, robustness, and sensitivity, informa-
tion regarding their ADME (absorption, distribution,
metabolism, and excretion) should be used to further
evaluate the performance of the marker as a BFI. Other
issues to be evaluated include sample collection and
preparation, as well as the analytical method, which
should be simple and easy to reproduce. For example,
collection of biopsies is a highly invasive procedure, and
except for special cases, this is commonly avoided in
nutrition-related studies.
The resulting list of putative BFIs should represent the
best current knowledge and therefore also points to
current knowledge gaps. The putative BFIs still need care-
ful validation in order for them to be used in nutrition
studies [6]. The list as such also represents a resource for
development of analytical procedures for food intake or
compliance assessment and for work on feature identifica-
tion in metabolomics studies on BFIs. Similar procedures
should work also for other biomarkers of dietary exposure,
i.e., for nutrient intake biomarkers or non-nutrient intake
biomarkers, but this would need to be carefully considered
in future work.Conclusion
Guidelines for conducting a biomarker of food intake re-
view (BFIRev) have been detailed as an 8-step process.
Based on the information collected by an extensive
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strengths and weaknesses of each candidate biomarker
can be critically evaluated. This prepares for further valid-
ation to assess to which extent the candidate biomarker
could actually be considered a fully validated BFI.
The BFIRev guidelines help in listing all known candi-
date BFIs and prepare for further validation steps by
compiling the relevant studies and by examining the
strengths and weaknesses of these studies for the valid-
ation process. Conducting the BFIRev by these guide-
lines additionally points out knowledge gaps and
consequently the specific needs for additional studies
and/or additional information necessary to fully validate
each BFI.
Endnotes
1Please note that this abbreviation differs from the
abbreviation, FIB, used in other papers in this special
issue.
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